Education
About Us
Working with TipRanks
Follow Us
G Medical Innovations Holdings (GMVDF)
OTHER OTC:GMVDF
GMVDF Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.02
Previous CloseN/A
Volume16.62K
Average Volume (3M)50.74K
Market Cap
$25.99K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)2.18M
Price to Earnings (P/E)―
Beta-37.02
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding259,918,180
10 Day Avg. Volume46,598
30 Day Avg. Volume50,745
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.21% Other Institutional Investors
99.79% Public Companies and
Individual Investors
GMVDF FAQ
What was G Medical Innovations Holdings’s price range in the past 12 months?
G Medical Innovations Holdings lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is G Medical Innovations Holdings’s market cap?
G Medical Innovations Holdings’s market cap is $25.99K.
When is G Medical Innovations Holdings’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were G Medical Innovations Holdings’s earnings last quarter?
G Medical Innovations Holdings released its earnings results on Sep 15, 2021. The company reported -$0.51 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.51.
Is G Medical Innovations Holdings overvalued?
According to Wall Street analysts G Medical Innovations Holdings’s price is currently Overvalued.
Does G Medical Innovations Holdings pay dividends?
G Medical Innovations Holdings does not currently pay dividends.
What is G Medical Innovations Holdings’s EPS estimate?
G Medical Innovations Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does G Medical Innovations Holdings have?
G Medical Innovations Holdings has 259,918,180 shares outstanding.
What happened to G Medical Innovations Holdings’s price movement after its last earnings report?
G Medical Innovations Holdings reported an EPS of -$0.51 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -25.143%.
Which hedge fund is a major shareholder of G Medical Innovations Holdings?
Currently, no hedge funds are holding shares in GMVDF
Company Description
G Medical Innovations Holdings
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures ECG data continuously for up to 14 days. It develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. G Medical Innovations Holdings Ltd was incorporated in 2014 and is headquartered in Rehovot, Israel.
LogicMark
―
Entero Therapeutics
―
ReShape Lifesciences
―
SCWorx
―
Heart Test Laboratories, Inc.
―